TCT

This channel contains news about the annual Transcatheter Cardiovascular Therapeutics (TCT) conference presented by the Cardiovascular Research Foundation (CRF). It includes coverage from the annual meeting and links CRF news. TCT is the premier conference for the subspecialty of interventional cardiology, including the new subspecialty areas of transcatheter structural heart procedures. 

Resolute Onyx Stent With Improved Radiographic Visibility Found to Be Safe and Effective
News | Stents Drug Eluting | October 01, 2018
Resolute Onyx Stent With Improved Radiographic Visibility Found to Be Safe and Effective
October 1, 2018 — Recent results from the BIONYX randomized clinical study showed the novel, thin-strutted, polymer-...
read more
Boston Scientific Receives FDA Approval for Eluvia Drug-Eluting Vascular Stent
Technology | Stents Drug Eluting | October 01, 2018
Boston Scientific Receives FDA Approval for Eluvia Drug-Eluting Vascular Stent
October 1, 2018 — Boston Scientific announced that the U.S. Food and Drug Administration (FDA) has approved its...
read more
Magnitude Bioresorbable Scaffold Shows Low MACE, Restenosis Rates at Nine Months
News | Stents Bioresorbable | October 01, 2018
Magnitude Bioresorbable Scaffold Shows Low MACE, Restenosis Rates at Nine Months
October 1, 2018 — New results from the RENASCENT studies presented at the Transcatheter Cardiovascular Therapeutics (...
read more
Videos | Hemodynamic Support Devices | October 01, 2018
VIDEO: The Importance of Ventricular Unloading in AMI and Cardiogenic Shock
Nevin Kapur, M.D., FAHA, FACC, FSCAI, executive director, Cardiovascular Center for Research and Innovation, Tufts...
read more
Mitral Regurgitation Volume Reduced at One Year in REDUCE FMR Trial
News | Heart Failure | September 28, 2018
Mitral Regurgitation Volume Reduced at One Year in REDUCE FMR Trial
September 28, 2018 — Heart failure patients who received the Carillon Mitral Contour System in the REDUCE FMR clinical...
read more
Portico Transcatheter Aortic Valve Successfully Reduces Severe Aortic Stenosis at One Year
News | Heart Valve Technology | September 28, 2018
Portico Transcatheter Aortic Valve Successfully Reduces Severe Aortic Stenosis at One Year
September 28, 2018 — At one year following transcatheter aortic valve replacement (TAVR), implantation with the Portico...
read more
Local Anesthesia Safe and Effective for Intermediate- and High-Risk TAVR Patients
News | Heart Valve Technology | September 28, 2018
Local Anesthesia Safe and Effective for Intermediate- and High-Risk TAVR Patients
September 28, 2018 — The first randomized study to compare general versus local anesthesia during transcatheter aortic...
read more
Videos | Hemostasis Management | September 27, 2018
VIDEO: How to Achieve Hemostasis With Large Bore Device Access
Philippe Genereux, M.D., co-director of the structural heart program at the Gagnon Cardiovascular Institute at...
read more
FDA Approves Biotronik's PK Papyrus Stent for Coronary Perforations
Technology | Stents | September 27, 2018
FDA Approves Biotronik's PK Papyrus Stent for Coronary Perforations
September 27, 2018 — Biotronik recently announced U.S. Food and Drug Administration (FDA) approval of the PK Papyrus...
read more
Videos | Intravascular Imaging | September 26, 2018
VIDEO: Near Infrared Spectroscopy Detects, Aids Risk Assessment of Vulnerable Plaques
Ron Waksman, M.D., associate director of the division of cardiology and director of cardiovascular research and...
read more
MitraClip Reduces Mortality for Heart Failure Patients With Secondary Mitral Regurgitation
News | Heart Valve Technology | September 26, 2018
MitraClip Reduces Mortality for Heart Failure Patients With Secondary Mitral Regurgitation
September 26, 2018 — Patients with heart failure and secondary mitral regurgitation (MR) who remained symptomatic...
read more
Eluvia Drug-Eluting Stent Demonstrates Superior Patency in IMPERIAL Trial
News | Stents Drug Eluting | September 26, 2018
Eluvia Drug-Eluting Stent Demonstrates Superior Patency in IMPERIAL Trial
September 26, 2018 — Positive 12-month data from the late-breaking IMPERIAL trial was presented at the 2018...
read more
NIRS-IVUS Detects Patients and Plaques Vulnerable to Subsequent Adverse Coronary Events
News | Intravascular Imaging | September 25, 2018
NIRS-IVUS Detects Patients and Plaques Vulnerable to Subsequent Adverse Coronary Events
September 25, 2018 – New data demonstrate the correlation between the presence of non-flow-limiting, non-intervened-...
read more
Virtue Sirolimus-Eluting Balloon Demonstrates Positive Safety and Efficacy at Three Years
News | Drug-Eluting Balloons | September 25, 2018
Virtue Sirolimus-Eluting Balloon Demonstrates Positive Safety and Efficacy at Three Years
September 25, 2018 — Orchestra BioMed Inc. announced the three-year clinical results from its Sirolimus Angioplasty...
read more
Ancora Heart Announces Positive Interim Analysis of AccuCinch Ventricular Repair System for Heart Failure
News | Heart Valve Technology | September 24, 2018
Ancora Heart Announces Positive Interim Analysis of AccuCinch Ventricular Repair System for Heart Failure
September 24, 2018 — Ancora Heart Inc. announced positive clinical data from the company’s recently expanded U.S. early...
read more
© Copyright Wainscot Media. All Rights Reserved.